In this episode, GOLD is joined by two of the pharmaceutical industry’s most unwavering mental health advocates: Wendy Bartie, Senior Vice President, US Oncology, Bristol Myers Squibb, and Courtney Billington, President, Janssen Neuroscience. They discern what resources pharma companies should be making available to their employees, what the industry’s role is in supporting patient mental health and how they manage their own mental wellbeing.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Pressure on UK government over mental health https://www.emg-gold.com/post/pressure-on-uk-government-over-mental-health
The driving seat of organisational change https://www.emg-gold.com/post/the-driving-seat-of-organisational-change
Making a difference in terminal diseases https://www.emg-gold.com/post/making-a-difference-in-terminal-diseases
Routine vaccinations: road to recovery https://www.emg-gold.com/post/routine-vaccinations-road-to-recovery
